Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

Emma E. Craythorne*, Ghulam Mufti, Anthony W. duVivier

*Corresponding author for this work

    Research output: Contribution to journalLetterpeer-review

    31 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1064-1065
    Number of pages2
    JournalJournal of the American Academy of Dermatology
    Volume65
    Issue number5
    DOIs
    Publication statusPublished - Nov 2011

    Cite this